News Wire
Markets

2 Vanguard Index Funds to Buy Now -- They Can Beat the S&P 500 Over the Next Decade, According to Wall Street Analysts

By Mark GrundellYahoo FinanceDecember 17, 2025 at 9:32 AMBullish1 min read

Diversify with these Vanguard funds for potential long-term outperformance against the S&P 500

Wall Street analysts are spotlighting two Vanguard index funds, suggesting they offer a strategic advantage for investors aiming to beat the S&P 500. This indicates a confidence in their underlying asset allocation or sector focus for sustained growth.

Analyst sentiment: Bullish
What to watch next

Monitor quarterly fund performance reports and economic indicators for sustained outperformance potential.

Wall Street analysts are touting two specific Vanguard index funds as strong contenders to outperform the S&P 500 over the coming decade. This suggests that while generally a broad market proxy, these particular funds may offer a strategic advantage for investors seeking growth beyond the market average, potentially due to their specific sector overweighting or underlying asset allocation. The recommendation points to a belief in their long-term growth potential.

Amidst a bull run for broad market indices, Wall Street analysts are turning their attention to specific Vanguard index funds, identifying two that they believe possess the structural characteristics to outperform the S&P 500 over the next decade. While the S&P 500 remains a cornerstone for many portfolios, the rationale behind these recommendations typically stems from unique sector weightings or exposure to secular growth trends not fully captured by the broader market index. For investors, this insight suggests a potential opportunity to diversify beyond pure market capitalization-weighted, broad-market exposure. These funds likely offer a targeted approach, perhaps focusing on innovation-driven sectors, emerging technologies, or specific demographic shifts that analysts anticipate will generate superior returns. The emphasis is on long-term growth, rather than tactical, short-term plays, making these potentially attractive additions for patient capital. To gauge the validity of these projections, investors should regularly review the funds' underlying holdings and their performance relative to benchmarks. Key upcoming data points to watch include earnings reports from companies within their portfolios and any shifts in economic policy that could favor their specific sectors. Continued analysis of analyst sentiment and evolving market conditions will be crucial for confirming their long-term potential. The full implications for investors will depend on follow-through in price action, positioning data and forthcoming policy or earnings catalysts referenced above.

Related Articles

You May Also Like